Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation.
Saved in:
| Title: | Genetic determinants of chromatin reveal prostate cancer risk mediated by context-dependent gene regulation. |
|---|---|
| Authors: | Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA., Singler C; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Zacharia S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics Dana-Farber Cancer Institute, Boston, MA, USA., Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics Dana-Farber Cancer Institute, Boston, MA, USA., Morova T; Vancouver Prostate Centre University of British Columbia, Vancouver, British Columbia, Canada., Hach F; Vancouver Prostate Centre University of British Columbia, Vancouver, British Columbia, Canada., Ding Y; Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, USA., Schwarz T; Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, USA., Huang CF; Vancouver Prostate Centre University of British Columbia, Vancouver, British Columbia, Canada., Anderson J; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Fay AP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kalita C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA., Groha S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA., Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Functional Cancer Epigenetics Dana-Farber Cancer Institute, Boston, MA, USA., Wang V; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA., Linder S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Biomedical Engineering, Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands., Sweeney CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Biomedical Engineering, Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, The Netherlands., Lack NA; Vancouver Prostate Centre University of British Columbia, Vancouver, British Columbia, Canada.; School of Medicine, Koç University, Istanbul, Turkey., Pasaniuc B; Bioinformatics Interdepartmental Program, UCLA, Los Angeles, CA, USA.; Department of Computational Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.; Department of Human Genetics, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA., Takeda DY; Laboratory of Genitourinary Cancer Pathogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA., Gusev A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. alexander_gusev@dfci.harvard.edu.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. alexander_gusev@dfci.harvard.edu.; Division of Genetics, Brigham & Women's Hospital, Boston, MA, USA. alexander_gusev@dfci.harvard.edu., Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. mfreedman@partners.org.; Center for Functional Cancer Epigenetics Dana-Farber Cancer Institute, Boston, MA, USA. mfreedman@partners.org.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA. mfreedman@partners.org. |
| Source: | Nature genetics [Nat Genet] 2022 Sep; Vol. 54 (9), pp. 1364-1375. Date of Electronic Publication: 2022 Sep 07. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Nature Pub. Co Country of Publication: United States NLM ID: 9216904 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1718 (Electronic) Linking ISSN: 10614036 NLM ISO Abbreviation: Nat Genet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
